poisar

Stocks · News reference

TherapeuticsMD Q2 EPS $0.01 Down From $0.05 YoY, Sales $869.000K Down From $952.000K YoY

Aug 11, 2026, 8:30 PMBenzinga Newsdesk

TherapeuticsMD (NASDAQ:TXMD) reported quarterly earnings of $0.01 per share. This is a 80 percent decrease over earnings of $0.05 per share from the same period last year. The company reported $869.000 thousand in

Read original sourceMore stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

TXMD
Source
benzinga
Observed
Aug 11, 2026, 8:30 PM
Checked
Aug 11, 2026, 8:30 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading